MedPath

Effect of an education program on congenital heart disease

Phase 1
Conditions
congenital heart disease.
ventricular septal defect, Atrial septal defect, patent ductus arterios
Q21.0, Q21
Registration Number
IRCT2012080410489N1
Lead Sponsor
Vice chancellor for Research, Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

1. The children suffering from ASD, VSD, PDA 2. The children not suffering from other chronic diseases
3. Being less than 12 months
4. The family having no other children with congenital heart disease
5. The children not having under gone heart surgery.
Exclusion criteria:
1. The children death
2. Unwillingness to cooperate in the study
3. The children hospitalization during the intervention

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life. Timepoint: Before intervention, immediately after, and 2 months after the last educational session. Method of measurement: SF_36 Questionnaire.;Self - efficacy. Timepoint: Before intervention, immediately after, and 2 months after the last educational session. Method of measurement: Sherer General Self Efficacy questionnaire.
Secondary Outcome Measures
NameTimeMethod
Mental Health. Timepoint: Before intervention, immediately and 2 months after last training session. Method of measurement: GHQ-28 Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath